Multisystem inflammatory syndrome (MIS) in children is a rare condition known to be associated with COVID-19, but more research is needed to identify at-risk patients and guide public health ...

Young people between the ages of 12-20 have reported several cases of a multi-system inflammatory syndrome, otherwise known as MIS-C, where the immune system goes on overdrive after being vaccinated ...

Nearly 30% of children who were hospitalized for Covid-19 or MIS-C, a rare but serious Covid-related condition, had symptoms more than a couple of months after their diagnosis, a new study found. The ...

Although still rare, MIS-C after Covid-19 has been more common and more severe than previously reported, and there are significant racial disparities in cases, according to a study published Thursday ...

Though many children infected with COVID-19 experience mild symptoms or are asymptomatic, a small subset develop a dangerous complication called MIS-C, or multisystem inflammatory syndrome in children ...

New Delhi: Scientists demonstrated that it is safe for children and adolescents to get a COVID-19 vaccine after having multisystem inflammatory syndrome (MIS-C). The researchers found that there were ...

The study, published in JAMA Network Open on Jan. 5, looked at COVID-19 and MIS-C hospitalizations in 31 states between February and October 2021 for individuals younger than 21. There were 4,107 ...

A year into the pandemic, a new study by researchers at Children’s Hospital of Philadelphia and Penn Medicine confirms that children battling Multisystem Inflammatory Syndrome (MIS-C) have highly ...

NEW YORK, NY (March 4, 2022)--A new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has identified unique features of MIS-C, a rare but potentially deadly ...